Magna Pharmacia attended the ISTH 2026 (International Congress on Thrombosis and Haemostasis), which was held this year in Paris, from 11 to 15 July 2026. With almost 6,000 participants this year, most of whom were hematologists and transfusiologists, and a large number of plenary lectures, separate and parallel sessions, as well as symposia, this congress justified its status as one of the most important congresses in the field of hemostasis and thrombosis.
During the congress, through numerous presentations that had an educational character, but also through the presentation of clinical cases and experiences, the participants could get acquainted with the results of the latest research in the field of coagulation disorders and hemostasis, with a special focus on significant achievements in the field of diseases such as hemophilia, idiopathic thrombocytopenic purpura, thrombosis and thrombophilia. as well as other rare coagulation disorders. Numerous symposia have been organized on these topics, and one of the organizers of two symposia on the topic of rare coagulation disorders was Kedrion, partner of Magna Pharmacy.
ISTH 2026 provided all participants with a valuable opportunity for numerous business meetings and exchange of experiences, as well as gaining new knowledge in the therapeutic approach and improving the treatment of patients with coagulation disorders.